Doctor of Pharmacy (Pharm.D.)
Pharmacy
Howard University
2005
Salome Bwayo Weaver, Pharm.D., BCGP, FASCP, is a professor of pharmacy practice in the Department of Clinical and Administrative Pharmacy Sciences at Howard University College of Pharmacy. She has been a member of the Howard University faculty since 2005, advancing through the ranks from assistant professor to associate professor and, in 2022, to professor. Weaver earned her Doctor of Pharmacy degree from Howard University and completed a postdoctoral oncology fellowship at the Howard University College of Pharmacy. She is a licensed pharmacist in the District of Columbia and Maryland and is board certified in geriatric pharmacy.
Weaver’s academic and clinical work centers on pharmacy practice, geriatrics, oncology and patient-centered care, with a strong emphasis on improving outcomes for underserved populations. Her research includes clinical trials and funded projects addressing Alzheimer’s disease, opioid safety, health disparities and innovative pharmacy education and training programs. She has served as principal investigator and co-investigator on numerous grants supported by agencies including the National Institutes of Health, the Health Resources and Services Administration and the Food and Drug Administration, reflecting her commitment to advancing clinical research and public health.
In addition to her research, Weaver is deeply engaged in teaching, mentorship and academic leadership. She has taught a wide range of courses in integrated therapeutics, pharmacy jurisprudence, health policy and geriatric pharmacotherapy, and has mentored pharmacy students through clinical rotations and research experiences. She currently serves as director of faculty development at the College of Pharmacy and has held multiple leadership roles, including coordinator and co-director of fellowship programs. Through her teaching, research and service, Weaver is dedicated to preparing future pharmacists to become skilled clinicians and advocates for their patients and the profession.
Pharmacy
Howard University
2005
Co-Investigator: GSK/Howard University Medical Affairs Fellowship Grant; GSK Pharmaceuticals. Funded. $1,335,000. Project Period: July 1, 2022 – June 30, 2027.
Co-Principal Investigator: AIM-AHEAD Data Science Training Core (DSTC) Faculty Teaching Buyout Pilot Program; Howard University AIM-AHEAD DSTC/NIH. Funded. Agreement No: 1OT2OD032581-01. $30,000. Project Period: July 15, 2022 – August 30, 2023.
Financial toxicity refers to the financial strain and distress experienced by patients and families as a result of cancer treatment. Employment changes following diagnosis may reduce income and contribute to material hardship. This study evaluated whether post-diagnosis employment status is associated with food insecurity in a national sample of cancer survivors in the United States.
Disparities in Prescription Opioids Among a National Sample of Adult Cancer Patients 2012–2021
Cancer is a major public health issue and the second leading cause of death in the United States. Pain remains a serious sequela, with opioids commonly prescribed for pain management. This study examined racial and ethnic disparities in opioid prescriptions among adults with a history of cancer.
Sickle cell disease (SCD) primarily affects people of African American descent in the United States. Many individuals do not know their sickle cell trait (SCT) status or might not be aware of SCD. The purpose of this study was to assess SCD knowledge, awareness of SCT status, and its impact on relationships. A cross-sectional study was conducted from August 2018 to June 2019 among students at a Historically Black College and University. Logistic regression was utilized to determine if the student’s SCD knowledge and SCT status had a significant impact on the student’s choice of relationships. A total of 203 students participated in the study. Most were female (60.1%) and African American (84.7%). The proportion of correct responses on individual questions within a SCD knowledge assessment ranged from 55.2% to 90.6%. Health professional students (Adjusted OR = 4.47; 95% CI = 1.18, 16.96; p = 0.028) and those with SCT (Adjusted OR = 13.00; 95% CI = 1.72, 98.39; p = 0.013) reported that their potential partner’s SCT status would have an impact on their current and future relationships. A large number of students are not knowledgeable about SCD and few are aware of their SCT status.